Middle East and Africa Continuous Glucose Monitoring Market Report by Type, Age Group, Stages, End User, Countries and Companies Analysis 2026-2034

Middle East and Africa CGM Market Size & Forecast 2026-2034

The Middle East and Africa continuous glucose monitoring market is anticipated to grow at a stable pace due to the rising incidence of diabetes, increased awareness about healthcare, and easy availability of innovative healthcare technology. The market is forecasted to expand from US$ 320.44 Million in 2025 to US$ 855.30 Million by 2034, registering a CAGR of 11.53% from 2026-2034. This is further aided by the development of the healthcare infrastructure and the integration of technology in the digital healthcare segment.

Middle East and Africa Continuous Glucose Monitoring Market Outlook

Continuous Glucose Monitoring, or CGM, is an advanced medical technology in the care and management of people with diabetes meant to parallel glucose levels throughout the day and night in real time. CGM systems consist of a small sensor worn under the skin, a transmitter, and a receiver or smartphone app. The sensor continually measures glucose levels found in the interstitial fluid, furnishing real-time data, trend insight, and notifications related to high or low glucose levels. This provides both the patient and healthcare professional with the information to make appropriate choices regarding insulin dosing, diet, and lifestyle for better management of diabetes and the reduced risk of complications.

The Middle Eastern and African region is witnessing increased adoption of CGM solutions due to the rise in the prevalence of diabetes, especially in Saudi Arabia, the United Arab Emirates, and other African nations like South Africa and Egypt. Factors such as increased awareness in the Middle Eastern and African region, government efforts to upgrade the management of diabetics, as well as the rise in the use of smartphones and the need for remote monitoring solutions, are bolstering the adoption of CGM solutions.

Growth Drivers of the Middle East and Africa Continuous Glucose Monitoring Market

Rising Prevalence of Diabetes and Lifestyle-Related Diseases

The MENA regions have witnessed strong economic and urbanization growth, resulting in lifestyle and diabetes prevalence changes. The estimated data released by the IDF in 2021 showed that the MENA region recorded the largest regional prevalence, 12.2%, and is expected to see an 86% rise in 2045. Qatar, which is growing as one of the fastest-growing economies, records the second-highest prevalence of Type 2 Diabetes patients within the MENA regions, and obesity is identified as the major risk factor among patients there. The rising prevalence of diabetes is identified as a major contributing factor to the ever-growing Middle East and Africa continuous glucose monitoring systems market. A sedentary lifestyle, unhealthy food habits, growing obesity, and increasing urbanization have dramatically escalated Type 1 and Type 2 Diabetes cases across the region collectively. The Gulf Cooperation Council states are listed among regions that have recorded some of the highest cases of diabetes prevalence across the globe, thus there is a substantial growing interest in more advanced monitoring systems needed to track blood glucose levels more accurately and continuously.

Advancements in Healthcare Infrastructure and Digital Health Adoption

Upgrades in their healthcare infrastructure and the increasing adoption of digital technologies in the healthcare segment are contributing to the growth of the CGM market in the MEA region. Encouraged by their respective governments, various investments are being made in upgrading hospitals and clinics, including the development of tele-health platforms. CGM technology closely fits in with tele-health platforms, allowing patients and doctors to constantly monitor and share their respective data. The integration of smartphones, cloud technology, and artificial intelligence capabilities in CGM technology has made them much easier to use and provide a host of benefits to patients and doctors alike. Increasing awareness about the advantages of constant monitoring is also contributing to the growth of the CGM market in the MEA region. June 2023, SANTECHTURE, a leading technology firm, unveiled two new RCM offerings in Riyadh, named THYNK and CODEMINE, both of which utilize artificial intelligence technology to improve the quality of documentation, medical coding, and revenues of various medical providers in Saudi Arabia, in accordance with the reforms of the 'Vision 2030' initiative.

Government Initiatives and Growing Awareness of Preventive Care

Government initiatives regarding the better management of diabetes and the promotion of preventive healthcare are helping the adoption of CGM considerably. Countries in the Middle East have implemented many national initiatives related to diabetes, screening, and creating awareness about the increasing burden of diabetes in the region. Insurance and the concept of reimbursing the cost of innovative diabetes management technology are improving slowly, especially in the developed healthcare setups of the region. Health education initiatives by organizations and manufacturers are increasing patient awareness about the benefits of CGM, like the fact that it leads to better patient quality of life and reduced visits to the hospital. With the increasing focus on preventive healthcare, the importance of CGM technology in the long-term management of diabetes is being recognized. The Ministry of Health and Prevention of the United Arab Emirate government introduced the National Unified Licensing Platform in February 2025. This platform integrates the various licensing services of the different authorities of the country for healthcare professionals.

Challenges of the Middle East and Africa Continuous Glucose Monitoring Market

High Cost and Limited Reimbursement Coverage

The high cost of devices is still a significant barrier found in the Middle Eastern and African markets of Continuous Glucose Monitoring. The cost of using Continuous Glucose Monitoring solutions such as sensors, transmitters, and software subscriptions is also relatively high in comparison with the cost of traditional methods of blood glucose monitoring. The lack of consistent reimbursement practices in many of these countries makes it quite expensive and hence creates a barrier for adoption among many of these populations. However, the penetration of Continuous Glucose Monitoring use has been somewhat high in the more affluent GCC states.

Limited Awareness and Access in Rural and Underserved Areas

There is also a dearth of awareness about the need for such a high level of diabetes treatment. Many parts of the African continent and even the Middle Eastern parts lack developed healthcare facilities. This also includes a lack of professionals. Many patients tend to rely on traditional methods for their monitoring. The need for such a treatment may not even be educated by many. Many also lack the connectivity necessary for such a device.

Middle East and Africa CGM Sensors Market

The Middle East and Africa market for CGM sensors is the primary drive for the continuous glucose monitors market since it is the sensor that monitors the level of glucose in the body. The market witnesses a boost with the rising number of diabetic patients as well as increased adoption rates for advanced technology. CGM sensors are made with comfort, accuracy, and a prolonged lifespan. They are apt for the treatment management system. In the Middle East, a robust healthcare system, high disposable income, and insurances drive the adoption of CGM system components. In Africa, awareness about the product boosts adoption, mainly in urban regions where medical technology usage is on the rise. Repeated purchases, as CGM sensor requirements keep changing frequently, also boost market growth. Advances in technology to improve the lifespan of CGM sensors or lower their costs would also increase adoption rates.

Middle East and Africa CGM Receivers Market

The Middle East and Africa market for CGM receivers is due to the need for easy-to-use receivers, which will enable hospitals, as well as patients, to monitor and track the level of glucose in the blood. Advancements in the technological aspects of CGM receivers, such as screen technology, battery life, and wireless connectivity, and the fact that these receivers offer simple and easy glucose monitoring, which can be helpful in regions with different technology penetration, are the factors driving the market. With the recommendation by healthcare providers of CGM Systems, the market is set to grow steadily at the Middle East and Africa level.

Middle East and Africa CGM Hospitals Market

Hospitals are one of the major end-user segments of the CGM market in the Middle East and Africa. CGM systems find increasing applications in hospitals for the management of glucose levels among diabetic patients, especially in intensive care units, maternity wards, and post-surgical care. Continuous monitoring also enables clinicians to achieve better glycemic control with fewer complications, hence improving patient outcomes. In the Middle East, government investments in developing advanced hospital infrastructure strongly support the adoption of CGMs. In Africa, private and tertiary hospitals are gradually adopting CGM technologies to improve the management of diabetes. The growing focus on digital health and remote patient monitoring further supports the use of CGMs in hospital settings across the region.

Middle East and Africa CGM Homecare Settings Market

The market for homecare settings of CGM in the Middle East and Africa is growing as more diabetic patients can be treated outside clinical settings. CGM systems ensure convenience, real-time alerts, and continuity in data for patients to make informed decisions regarding diet, medication, and lifestyle. Homecare settings are being increasingly adopted due to rising awareness among people toward self-care, increasing adoption of smartphones, and the emergence of telemedicine services. Strong access to healthcare and insurance coverage in the Middle East help people continue with home-based care using CGM. The African region is seeing a gradual growth rate as more people become informed about its use and CGM devices become more affordable. Home-based CGM will be increasingly important in long-term diabetes management throughout the region.

Saudi Arabia CGM Market

The Saudi Arabia CGM market is expanding steadily due to one of the highest prevalence of diabetes and the focus of the government on improving healthcare infrastructure and digital transformations of the healthcare industry. Improved hospital infrastructure, high use of smartphones, and steadily improving insurance facilities make CGM systems even more attractive and accessible to patients with diabetes. Hospitals and endocrinologists are increasingly prescribing CGM systems to patients with both types of diabetes: Type 1 and insulin-dependent patients with Type 2 diabetes. An increase in patient familiarity with the advantages of real-time glucose monitoring and preventing complications is also fueling the use of CGM systems. Telemedicine and remote monitoring services are adding to the increased use of CGM systems in home settings for patients with diabetes. November 2025 - Roche today announced that the Accu-Chek SmartGuide Continuous Glucose Monitoring (CGM) system is launched in the ME - starting with the first rollout in Kuwait, Qatar, KSA, and others to shortly follow starting with UAE soon. This important step means that patients with diabetes aged 18+ years can now benefit from the new improved glucose monitoring and AI-powered predictive capabilities of this new technology innovation tool.

South Africa CGM Market

The South Africa CGM market is growing gradually due to an increasing number of diabetes cases and adoption of advanced diabetes management technology. Only private healthcare entities and urban hospital chains are currently adopting CGM technologies in a significant manner for people with Type 1 diabetes and those undergoing intensive insulin therapy. Growing physician and patient acceptance of the benefits of continuous monitoring has been improving adoption levels. Mobile phone-based CGM technology has gained favor owing to their user friendliness. High costs and lack of reimbursements in the public health system are major concerns. In November 2025, Roche proudly announced that its Accu-Chek SmartGuide continuous glucose monitoring system is now available in South Africa. This major development means that individuals aged 18 years and older with diabetes are now able to take advantage of this advanced glucose monitoring system’s capabilities and predictive powers with artificial intelligence.

United Arab Emirates CGM Market

The UAE CGM market is aided by high expenditure on healthcare, advanced medical infrastructure, and a strong focus on preventive healthcare. Also, the prevalence of diabetes is high in the country; thus, the adoption rate for advanced glucose monitoring systems is encouraged. Also, government support for smart healthcare solutions like digital healthcare, telemedicine, and patient monitoring systems helps boost CGM adoption in hospitals and homecare settings. Moreover, the high adoption rate of smartphones by the population makes it easy for the adoption of smartphone-controlled CGM systems in the market. Also, a major contribution in the growth of the CGM market comes from private hospitals and clinics, where CGMs are being promoted along with diabetes management solutions. With increased investment in smart healthcare solutions by the UAE government, adoption rates for CGM systems will experience a boost in the country. July 2024, Sibionics, a company that focuses on developing implantable medical devices, has received product marketing approval for its GS1 Continuous Glucose Monitoring (CGM) system by the Ministry of Health & Prevention (MoHAP) in the UAE government.

Market Segmentation

Component

• Sensors
• Transmitters
• Receivers

End User

• Hospitals
• Homecare Settings
• Others

Countries

• Saudi Arabia
• UAE
• Qatar
• Bahrain
• Iran
• Egypt
• Oman
• South Africa
• Rest of the Middle East and Africa

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Company Analysis:

• Dexcom
• Medtronic
• Senseonics
• Abbott Diabetes Care
• GlySens

Report Details: